Thailand flu diagnostic and treatment market is projected to grow at a CAGR of 9.57% throughout the forecast period. The flu diagnostic and treatment market in Thailand is poised to surge at a significant rate during the coming years owing to the fact that the easy availability of cheaper OTC medicines for cough, cold and allergies along with the rapid increase in the influenza cases throughout the country are collectively contributing to positively impact the market growth in the country. However, the lack of effectiveness of such medications has called in the need for more advanced vaccinations and treatment efforts; thus fuelling the market in the coming years.
The growth in the number of cases is one of the prime factors which is projected to supplement the demand for flu diagnostic and treatment solutions in the country which is thereby projected to boost the flu diagnostic and treatment market in Thailand during the coming years. For instance, according to the Bureau of Emerging Infectious Diseases which comes under the Ministry of Public Health’s Department of Disease Control, in 2017, the total number of influenza cases were reported to be around 165,000, an increase of 50,000 cases was also observed by the end of 2017 which further shows the growing intensity of influenza virus throughout the country which is anticipated to positively impact the market growth of flu diagnostic and treatment in the country during the forecast period and beyond. Furthermore, the rising number of flu cases is expected over the years which is also considered as an important factor for the flu diagnostic and treatment market to surge during the forecast period and beyond. Furthermore, the availability of cheaper OTC medicines is also positively impacting market growth in Thailand. In addition, the advisory committee namely, Immunization Practice in Thailand also provides seasonal influenza vaccinations for high-risk population groups, the government exclusively purchase vaccines for such people, also shows the potential for the market to surge during the coming years.
Thailand flu and diagnostics market has been segmented on the basis of the type of flu, offering, age group, and end-user. On the basis of the type of flu, the market has been classified on the basis of type A and type B. By offering, the market has been segmented into diagnostics and therapeutics. By the age group the market has been segmented on the basis of 0-14 years, 15-64 years and >=65 years. By the end-user, the segmentation has been done on the basis of hospital laboratory, outpatient clinic, and reference laboratory.
Prominent key market players in Thailand flu diagnostic and treatment market include Abbott, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific and 3M among others. These companies hold a noteworthy share in the market on account of their good brand image and product offerings. Major players in Thailand flu diagnostic and treatment market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last two years.